Skip to main content
. 2020 Feb 28;11:174. doi: 10.3389/fphar.2020.00174

Figure 1.

Figure 1

Lactoferrin suppressed hypoxia-inducible factors (HIF) activation in a luciferase assay. (A) Administration of lactoferrin significantly suppressed CoCl2-induced HIF activation in ARPE19 cells. (B) Administration of lactoferrin significantly suppressed CoCl2-induced HIF activation in 661w cells. **p < 0.01, ***p < 0.001, compared with CoCl2 without topotecan and lactoferrin, n = 3.